Back

Axsome Therapeutics, Inc. (AXSM)
PharmaceuticalsAXSM · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$168.35
−1.02%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$-3.68
ROE
-349.4%
Gross margin
92.6%
Debt/Equity
4.03x
Revenue growth
57.4%
Axsome Therapeutics, Inc. — company intelligence
Earnings surprises
Q2 2026$-0.99 vs $-0.86 est-14.9%
Q1 2026$-1.26 vs $-0.91 est-37.9%
Q4 2025$-0.56 vs $-0.68 est+18.0%
Q3 2025$-0.94 vs $-0.88 est-6.5%
Analyst consensus · 28 analysts
26 Buy2 Hold0 Sell
Updated Oct 9, 2026
Insider activity · 90 days
0 buys0 sellsnet +0 shares
TABUTEAU HERRIOTother 4,660 · Aug 6, 2026
TABUTEAU HERRIOTother 45,004 · Aug 5, 2026
Recent SEC filings
4 — Insider transaction reportSep 3, 2026
8-K — Material event reportAug 10, 2026
10-Q — Quarterly reportAug 10, 2026
Latest news
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.